Capricor Therapeutics faces class action lawsuit over alleged securities law violations
News provided byCapricor Therapeutics, Inc · 2 min read
LOS ANGELES, Sept. 3, 2026 /CourierPR/ -- Capricor Therapeutics, Inc., the biotechnology firm listed on the NASDAQ under the ticker CAPR, is facing a class action lawsuit for alleged securities law violations. The lawsuit, filed by The DJS Law Group, alleges that the company made false and misleading statements to the market during a specific period.
The case centers around the company's handling of clinical data analysis for its drug Deramiocel. According to the complaint, Capricor modified the statistical analysis plan without obtaining the necessary approval from the U.S. Food and Drug Administration (FDA) before resubmitting a Biologics License Application. This action, the lawsuit claims, rendered the company's public statements false and misleading throughout the class period.
The class period for the lawsuit extends from December 17, 2025, to July 26, 2026. Shareholders who purchased CAPR shares during this timeframe are encouraged to contact The DJS Law Group to discuss their potential role as a lead plaintiff. Being a lead plaintiff is not a prerequisite for participating in any potential recovery.
"Capricor's actions during this period significantly impacted the value of investors' shares," said David J. Schwartz, a founding partner of The DJS Law Group. "Our firm focuses on enhancing investor returns through balanced counseling and aggressive advocacy, and we are committed to holding Capricor accountable for these alleged violations."
The DJS Law Group, known for its expertise in securities class actions and corporate governance litigation, has a proven track record of representing some of the world's largest and most sophisticated hedge funds and alternative asset managers. The firm's primary focus is on providing balanced legal advice and robust representation to its clients.
Investors who believe they may have suffered a financial loss due to these alleged violations are urged to contact The DJS Law Group to learn more about their rights and the potential for recovery.
The deadline for those interested in joining the lawsuit is September 28, 2026.
This legal action is part of ongoing efforts to hold companies accountable for misleading statements and to protect the interests of shareholders. Shareholders are encouraged to act quickly to ensure their rights are protected.